The physicochemical properties, antitumor efficacy, and mechanisms of action of the HA-DOX-CDDP micelles were investigated using CD44- normal fibroblast cells (NIH-3T3) and CD44+ breast cancer cells (4T1) in vitro, and in mice bearing 4T1 breast tumors in vivo. This evidence concerns the gene CD44 and breast carcinoma.